UIM
LXRX icon

USS Investment Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

USS Investment Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,741,942
Closed -$22.6M – 120
2018
Q1 		$22.6M Sell
2,741,942
-765,958
-22% -$7.08M 0.25% 68
2017
Q4 		$34.7M Hold
3,507,900
– – 0.4% 52
2017
Q3 		$43.1M Hold
3,507,900
– – 0.33% 55
2017
Q2 		$57.7M Buy
+3,507,900
New +$54.3M 0.54% 46

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return
SGA
Sector Gamma AS Oslo, Norway $461M AUM 33.26% 1-Year Est. Return

USS Investment Management's LXRX Position: Q2 2018 in Review

USS Investment Management sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2018, closing a stake of 2,741,942 shares — an estimated $22.6M sold.

USS Investment Management first reported a position in LXRX in Q2 2017 and held it in 4 quarters. The position peaked at $57.7M in Q2 2017. 121 funds tracked by Wall St. Rank hold LXRX as of Q2 2018.

  • USS Investment Management reported no remaining Lexicon Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • USS Investment Management sold 2,741,942 Lexicon Pharmaceuticals shares in Q2 2018, an estimated $22.6M.
  • USS Investment Management first reported a position in Lexicon Pharmaceuticals in Q2 2017 and held it in 4 quarters.
  • USS Investment Management's Lexicon Pharmaceuticals position peaked at $57.7M in Q2 2017.
  • 121 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2018.

Based on USS Investment Management's 13F filing for Q2 2018, filed 24 Jul 2018.